
Originally Posted by
dvd
Due to personal reasons I missed a dose then went on just TB-500 for one week and then BPC-157 another and can say so far that BPC-157 is a poor choice for bursitis and probably tendonitis. Seems like most of the research about BPC-157 is healing tendon and muscle injury not an inflammatory process. TB-500 is ok at inflammation but I have a feeling it's not as good as other tested antiinflammatory agents like EGCG, Allantoin or Resveratrol.
Once I get the Phlojel and the ingredients I plan on making a transdermal containing EGCG, Allantoin and Resveratrol and testing it for bursitis. I really think the peptide response to inflammation just isn't that great so far.
I also think that both compounds use the IGF-1 pathway somehow in how they work. Just a guess on my part.
There are other, better antiinflammatory agents on Pubmed but most are at the $100+g cost so these three were chosen based on COX2 inhibition.